Kroger Co to merge with specialty pharmacy Axium Pharmacy

By Admin
Share
American retailer The Kroger Co will be buying the outstanding shares of Axium Pharmacy Holdings, Inc, a leading specialty pharmacy to create merger of...

American retailer The Kroger Co will be buying the outstanding shares of Axium Pharmacy Holdings, Inc, a leading specialty pharmacy to create merger of two companies.

The specialty pharmacy Axium Pharmacy provides drug therapies and patient-support services to treat chronic, genetic and other complex medical conditions such as cancer, Hepatitis C, Rheumatoid arthritis, multiple sclerosis and other chronic care conditions.

This alliance will give Kroger enhanced capabilities to serve customers who require complex drug therapies, and to deliver those therapies at greater value to customers and insurance players.

The financial terms were not disclosed. Lincoln Lutz, Kroger’s Vice President said, “Kroger and Axium are a strategic fit as we look to enter the high-growth specialty pharmacy business.” Mr. Lincoln also said, “The combination of Axium’s expertise and Kroger’s 1,950 pharmacy locations 91 Little Clinic locations, and pharmacists who provide health coaching, biometric screening and other wellness services will deliver positive health outcomes for our patients, cost savings for insurance payers, and unique services for physicians.”  

Kroger’s President and COO said, “This partnership supports Kroger’s long-term growth plans, with strong return on invested capital.” Axium will continue to operate as an independent company within the Krogers family. 

Kroger employs more than 339,000 associates who serve customers in 2,425 supermarkets and multi-department stores in 31 states.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma